Forensic Analysis · Trading Companies & Distributors · as of Aug 11, 2026
Resideo Technologies, Inc. (REZI)
A forensic read on Resideo Technologies, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Grey Zone
Financial health
2.6
Distress distance
Clean
Earnings quality
5
Forensic signals
-7.3
P / E (ttm)
-18.1%
ROE
$3.7B
Market cap
0.89%
Dividend yield
10.5%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Resideo Technologies, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 2.6, placing it in the Grey zone. 5 forensic signals were flagged in its latest SEC filings, led by shareholder returns — halted.
What the filings flag
stopped
FY2024→FY2025
Shareholder returns — halted.Capital returns have STOPPED — $1M of buybacks + dividends in FY2024, but ~$0 in FY2025. A halt usually means the company is conserving cash.
+16.6%
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets grew +16.6% relative to their own average in FY2025 — scaled by NOA itself, not total assets (see the Forensic Screens card's differently-scaled Sloan Accrual Ratio for that read). Accruals are building faster than is comfortable — part of profit is sitting in the balance sheet rather than turning to cash. The build is led by inventory up +9% against +9% in cost of sales. The cash-flow cross-check agrees: reported earnings ran ahead of operating cash by 12% of net operating assets.
90d
FY2024→FY2025
Inventory days.Days inventory outstanding moved from 82 to 90 FY2024→FY2025 (against cost of goods sold; inventory +9% vs +9% in cost of sales). Inventory is building a little faster than sales — watch for markdowns.
7.9%
FY2025
Return on invested capital.Return on invested capital is 7.9% in the latest fiscal year and steady — around its ~8% cost of capital, so growth is roughly value-neutral.
+0.0%/yr
FY2022–FY2025
Share count.Diluted share count changed +0% over the last 3 years to FY2025 (+0.0%/yr). Roughly flat — the count is neither shrinking nor growing meaningfully. Per-share value isn't being meaningfully helped or hurt by the count.
Key fundamentals
Latest Revenue$7.47B
Revenue Growth YoY+10.5%
Revenue CAGR (3yr)+5.5%
Net Margin-7.1%
Free Cash Flow-$1.25B
Return on Equity-18.1%
Debt / Equity1.09x
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Resideo Technologies, Inc.'s actual 10-K/10-Q/8-K filings?